retatrutide type 2 diabetes phase 2 trial for Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with diabetes: a randomised, double-blind, placebo and A Study of Retatrutide (LY3437943)

Interventions: Drug: Tavapadon Drug: Placebo Primary Outcome Measures: Change From Baseline in the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Parts II and III Combined Score The Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) retains the four-scale structure with a reorganization of the various subscales

These minimally invasive procedures change the amount of food your stomach can hold and/or how your body absorbs calories and nutrients, helping you lose weight safely and effectively

Diabetologia (2013) 56(11):245666

Comparative distribution and metabolism of two 14 C-labelled chlorinated paraffins in Japanese quail coturnix coturnix japonica

Molecular portraits of human breast tumours